Evaluation of new gastro-intestinal prokinetic (ENGIP-I) study.
J Indian Med Assoc
; 2005 Oct; 103(10): 559-60
Article
in En
| IMSEAR
| ID: sea-103255
ABSTRACT
The ENGIP-I study was conducted to investigate the efficacy, and safety of itopride in patients of gastro-oesophageal reflux disease. There were significant reductions in heartburn frequency, heartburn severity, gastro-oesophageal regurgitation frequency at day 3 only. ENGIP-I study concluded that itopride was well tolerated by patients and appears to be the drug of choice in patients with gastro-oesophageal reflux disease.
Full text:
1
Index:
IMSEAR
Main subject:
Safety
/
Benzamides
/
Benzyl Compounds
/
Aged
/
Female
/
Humans
/
Male
/
Gastroesophageal Reflux
/
Adolescent
/
Treatment Outcome
Type of study:
Clinical_trials
Country/Region as subject:
Asia
Language:
En
Journal:
J Indian Med Assoc
Year:
2005
Type:
Article